Inflammatory bowel disease, osteoarthritis, rheumatoid arthritis, fibromyalgia, systemic lupus erythematosus, gout, juvenile idiopathic arthritis, infectious arthritis, psoriatic arthritis, ankylosing spondylitis, reactive arthritis, scleroderma, polymyalgia rheumatica, and other conditions are best treated with anti-inflammatory drugs. Increase in these diseases' prevalence further stimulates Autoimmune Disease Treatment Market expansion. Currently, a variety of autoimmune diseases are treated using drugs including Adalimumab, Etanercept, Infliximab, Abatacept, Certolizumab, Golimumab, Ustekinumab, Tocilizumab, Secukinumab, and others. Anti-inflammatory medications are widely available, and in some nations, their preferred use and advantageous reimbursement contribute to the market's expansion.
Read more @ https://digitalgrowinfo.blogspot.com/2022/10/autoimmune-disease-treatment-autoimmune.html
